Psychedelic Legislation Tracker

Complete tracker of 237 psychedelic policy bills in 41 U.S. states, including decriminalization measures, regulated-access programs, and research authorizations. Status, sponsor, and latest action for every bill.

U.S. psychedelic legislation
BillStateSubstanceTypeStatusSponsorLast action
SB1224 - The California Emerging Therapies Research Partnership Act. California Psilocybin Clinical Research Passed Committee Brian Jones Aug 13, 2026
SB43 - Provides relative to psychedelic-assisted therapy. (8/1/26) Louisiana Psilocybin Therapeutic Access Signed into Law Patrick McMath Aug 1, 2026
H4200 - Authorizing a pilot for the use of psychedelics in licensed treatment facilities Massachusetts Psilocybin Clinical Research In Committee James O'Day Jul 23, 2026
H2203 - Establishing a pilot program for access to regulated psilocybin Massachusetts Psilocybin Clinical Research In Committee Marjorie Decker Jul 22, 2026
HB1772 - Relative to prescribing ibogaine for investigational use only. New Hampshire Ibogaine Clinical Research Signed into Law Michael Moffett Jul 20, 2026
HB9559 - IBOGAINE Act Initiating Biomedical Outcomes to Garner Advancements into Innovative Neuroplastogen Efficacy Act Federal Multiple Therapeutic Access In Committee Morgan Luttrell Jul 17, 2026
H4986 - Relative to therapeutic psilocybin treatment centers Massachusetts Psilocybin Therapeutic Access Passed Committee Joint Committee on Public Health Jul 9, 2026
SB1188 - Approved medications; scheduling; prescription authority Arizona Psilocybin Therapeutic Access Signed into Law Thomas Shope Jun 22, 2026
SB1752 - Mescaline; possession; sale; commercial use Arizona Mescaline Therapeutic Access Passed One Chamber Theresa Hatathlie Jun 13, 2026
SB1538 - Controlled substances; approval; workers' compensation Arizona Psilocybin Therapeutic Access Passed One Chamber Kevin Payne Jun 11, 2026
HB6020 - Health: research; participation in ibogaine clinical trials; provide for. Amends sec. 7212 of 1978 PA 368 (MCL 333.7212) & adds secs. 2222, 2222a & 2222b. Michigan Ibogaine Clinical Research In Committee Jaime Greene Jun 9, 2026
HB1325 - Natural Medicine Colorado Psilocybin Therapeutic Access Signed into Law Jarvis Caldwell Jun 4, 2026
SB00191 - An Act Concerning The Psychedelic-assisted Therapy Pilot Program. Connecticut Psilocybin Clinical Research Signed into Law Public Health Committee Jun 4, 2026
SB2149 - AN ACT to amend Tennessee Code Annotated, Title 9; Title 33; Title 53; Title 63 and Title 68, relative to clinical trials. Tennessee Psilocybin Clinical Research Signed into Law Page Walley May 27, 2026
HB2075 - AN ACT to amend Tennessee Code Annotated, Title 9; Title 33; Title 53; Title 63 and Title 68, relative to clinical trials. Tennessee Psilocybin Clinical Research Signed into Law Bryan Terry May 27, 2026
SB2772 - PSILOCYBIN ADVISORY BOARD Illinois Psilocybin Clinical Research In Committee Rachel Ventura May 15, 2026
AB2489 - Controlled substances: research. California Psilocybin Clinical Research In Committee Josh Lowenthal May 14, 2026
HB717 - Medical Practice Act; regulation of the administration of psychedelic-assisted treatment and therapy; provide Georgia Psilocybin Therapeutic Access Signed into Law Sharon Cooper May 12, 2026
HB3834 - Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; Office of the State Treasurer; adverse licensing action; effective date. Oklahoma Ibogaine Clinical Research Signed into Law Stan May May 12, 2026
HB382 - Controlled substances; Schedule I; psilocybin; revise a provision Georgia Psilocybin Scheduling Signed into Law Ron Stephens May 11, 2026
S05303 - Allows the growth, cultivation, and regulated adult use of psilocybin for the treatment of certain health conditions; provides for the certification of support service providers and the licensure of cultivators. New York Psilocybin Therapeutic Access In Committee Julia Salazar May 8, 2026
A02142 - Allows the growth, cultivation, and regulated adult use of psilocybin for the treatment of certain health conditions; provides for the certification of support service providers and the licensure of cultivators. New York Psilocybin Therapeutic Access In Committee Amy Paulin May 8, 2026
SB1767 - Modifies provisions relating to alternative therapies and treatments, including psilocybin Missouri Psilocybin Therapeutic Access Died Rick Brattin May 7, 2026
HB2817 - Creates provisions relating to ibogaine treatment Missouri Ibogaine Therapeutic Access Passed Committee Matthew Overcast May 7, 2026
HB1717 - Modifies provisions relating to alternative therapies and treatments, including psilocybin Missouri Psilocybin Therapeutic Access Passed Committee Richard West May 7, 2026
HB1809 - Authorizing the medical use of psilocybin through a program established in the department of health and human services. New Hampshire Psilocybin Therapeutic Access Passed One Chamber Buzz Scherr May 7, 2026
S1018 - The HEAL Act North Carolina Psilocybin Appropriations / Administrative Introduced Sophia Chitlik May 5, 2026
HF978 - A bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.) Iowa Psilocybin Therapeutic Access In Committee Ways and Means May 1, 2026
S01817 - Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction. New York Ibogaine Clinical Research Died Nathalia Fernandez Apr 29, 2026
SB3199 - Relating To Mental Health. Hawaii Psilocybin Clinical Research Passed One Chamber Chris Lee Apr 29, 2026
HB427 - Task Force on Responsible Use of Natural Psychedelic Substances - Extension Maryland Psilocybin Therapeutic Access Signed into Law Pam Guzzone Apr 28, 2026
SB336 - Task Force on Responsible Use of Natural Psychedelic Substances - Extension and Membership Maryland Psilocybin Therapeutic Access Signed into Law Brian Feldman Apr 28, 2026
HF2906 - Psilocybin therapeutic use program established; protections for registered patients, designated cultivators, registered facilitators, and health care practitioners established; rulemaking authorized; civil actions authorized; fees established; advisory committee established; criminal penalties provided; and money appropriated. Minnesota Psilocybin Therapeutic Access Died Andrew Smith Apr 22, 2026
SB031 - Use of Prescription Product with Controlled Substance Colorado Psilocybin Scheduling Signed into Law William Lindstedt Apr 20, 2026
SF3971 - Psilocybin therapeutic use program establishment Minnesota Psilocybin Therapeutic Access In Committee Clare Oumou Verbeten Apr 20, 2026
SB1682 - Modifies provisions relating to alternative therapies and treatments, including psilocybin Missouri Psilocybin Therapeutic Access Died Tracy McCreery Apr 16, 2026
SB77 - AN ACT relating to ibogaine research in the Commonwealth. Kentucky Ibogaine Clinical Research Signed into Law Donald Douglas Apr 14, 2026
HB4040 - Relating to health care; and declaring an emergency. Oregon Psilocybin Clinical Research Signed into Law Apr 13, 2026
HF4577 - Psilocybin therapeutic use program established; protections for registered patients, registered suppliers, registered facilitators, and health care practitioners established; civil actions authorized; advisory committee established; and money appropriated. Minnesota Psilocybin Therapeutic Access In Committee Max Rymer Apr 9, 2026
H7756 - Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the US FDA's program, mandate that RI department of health establish rules regulations. Rhode Island Psilocybin Trigger Law In Committee Brandon Potter Apr 9, 2026
HB1347 - Psilocybin; Board of Pharmacy to reschedule upon federal scheduling changes. Virginia Psilocybin Trigger Law Signed into Law Laura Jane Cohen Apr 6, 2026
SB379 - Psilocybin; Board of Pharmacy to reschedule upon federal scheduling changes. Virginia Psilocybin Trigger Law Signed into Law Jennifer Boysko Apr 6, 2026
SB1042 - Relating To Mental Health. Hawaii Psilocybin Clinical Research Passed One Chamber Chris Lee Apr 2, 2026
H4050 - To amend the General Laws, in relation to promoting the health and well-being of the residents of the Commonwealth of Massachusetts by establishing a comprehensive framework supporting public health and safety through regulated adult use, support services, and cultivation of psilocybin-containing fungi; and providing for taxation and appropriation thereof Massachusetts Psilocybin Legalization Tabled Patrick Kearney Apr 2, 2026
SB1581 - Establishes the "Veterans Mental Health Innovation Act" relating to ibogaine treatment Missouri Ibogaine Therapeutic Access Died Jason Bean Apr 1, 2026
HB4626 - Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine West Virginia Ibogaine Therapeutic Access Vetoed Ryan Browning Apr 1, 2026
HB2992 - HOPE PILOT PROGRAM Illinois Psilocybin Clinical Research In Committee Theresa Mah Mar 27, 2026
HB1143 - ILLINOIS CURE ACT Illinois Psilocybin Scheduling In Committee LaShawn Ford Mar 27, 2026
SB2184 - USE AND RESEARCH-ENTHEOGENS Illinois Psilocybin Scheduling In Committee Rachel Ventura Mar 27, 2026
SB906 - Permitting lawful prescription of crystalline polymorph psilocybin under FDA recommendations West Virginia Psilocybin Scheduling Signed into Law Vince Deeds Mar 27, 2026
H1726 - Relative to criminal disposition of limited psilocybin possession offenses Massachusetts Psilocybin Therapeutic Access In Committee Homar Gomez Mar 26, 2026
H1624 - Establishing a task force to study equitable access to psilocybin and other entheogenic plants Massachusetts Psilocybin Legalization In Committee Mike Connolly Mar 26, 2026
H1858 - Relative to removing criminal penalties for limited psilocybin possession Massachusetts Psilocybin Therapeutic Access In Committee Marc Lombardo Mar 26, 2026
HB314 - Ibogaine; authorize SDH to select a consortium to conduct a drug development clinical trial with, to secure FDA's approval of. Mississippi Ibogaine Clinical Research Signed into Law Sam Creekmore Mar 26, 2026
SB631 - "Veterans Mental Health Innovations Act"; enact Georgia Ibogaine Clinical Research Died Sonya Halpern Mar 25, 2026
SB0083 - Controlled Substance Scheduling Amendments Utah Psilocybin Therapeutic Access Signed into Law Evan Vickers Mar 24, 2026
SCR171 - Urging The Convening Of A Mental Health Emerging Therapies Task Force To Prepare The State For The Integration Of Breakthrough Therapies And To Explore Opportunities To Expand Clinical Trials, Research Partnerships, And Treatment Capacity In The State. Hawaii Psilocybin Clinical Research In Committee Chris Lee Mar 19, 2026
HB0390 - Veterans PTSD Clinical Research Amendments Utah Psilocybin Clinical Research Signed into Law Jennifer Dailey-Provost Mar 19, 2026
SR162 - Urging The Convening Of A Mental Health Emerging Therapies Task Force To Prepare The State For The Integration Of Breakthrough Therapies And To Explore Opportunities To Expand Clinical Trials, Research Partnerships, And Treatment Capacity In The State. Hawaii Psilocybin Clinical Research In Committee Chris Lee Mar 19, 2026
SF4485 - Psilocybin therapeutic use program establishment Minnesota Psilocybin Therapeutic Access In Committee Mark Koran Mar 17, 2026
H0899 - Adds to existing law to establish the Medical Advanced Healing Act. Idaho Psilocybin Therapeutic Access In Committee Health and Welfare Committee Mar 16, 2026
SB2056 - Controlled substances; provide for automatic scheduling of certain substance if federal scheduling occurs. Mississippi Psilocybin Scheduling Signed into Law Angela Turner-Ford Mar 13, 2026
HB563 - Controlled substances; provide for automatic scheduling of psilocybin after federal scheduling. Mississippi Psilocybin Scheduling Failed Sam Creekmore Mar 11, 2026
HB1099 - Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance. South Dakota Psilocybin Scheduling Signed into Law Tom Pischke Mar 10, 2026
SB4031 - Innovative Therapies Centers of Excellence Act Federal Psilocybin Therapeutic Access In Committee Ruben Gallego Mar 9, 2026
H0309 - Controlled Substances Florida Psilocybin Scheduling In Committee Justice Budget Subcommittee Mar 9, 2026
SF4204 - Psilocybin regulation provisions Minnesota Psilocybin Regulation In Committee Clare Oumou Verbeten Mar 9, 2026
HB4110 - Relating to ibogaine; prescribing an effective date. Oregon Ibogaine Therapeutic Access Failed Alek Skarlatos Mar 6, 2026
SB0114 - Controlled Substances Amendments Utah Psilocybin Therapeutic Access Failed Kirk Cullimore Mar 6, 2026
HB1296 - Mental health; pilot program to support clinical research of certain veterans and first responders suffering from certain conditions; provide Georgia Psilocybin Clinical Research Passed One Chamber Martin Momtahan Mar 6, 2026
LB877 - Designate certain substances as controlled substances (crystalline polymorph psilocybin CPP exemption preserved) Nebraska Psilocybin Trigger Law Signed into Law Sen. Robert Hallstrom (R) Mar 3, 2026
H7925 - Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the Food and Drug Administration (FDA) program, mandates that RI DOH establishes rules regulations. Rhode Island Psilocybin Trigger Law In Committee Brandon Potter Feb 27, 2026
SB0802 - Controlled substances: penalties; conduct associated with qualified psychoactive substances; exempt from criminal penalties in certain circumstances. Amends secs. 7401, 7403 & 7404 of 1978 PA 368 (MCL 333.7401 et seq.). Michigan Psilocybin Regulation In Committee Jeff Irwin Feb 26, 2026
HB2961 - Creates provisions relating to ibogaine treatment Missouri Ibogaine Therapeutic Access Passed Committee Richard West Feb 26, 2026
HB1643 - Modifies provisions relating to alternative therapies and treatments, including psilocybin Missouri Psilocybin Therapeutic Access Passed Committee Matthew Overcast Feb 26, 2026
HB2218 - Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act. Kansas Psilocybin Scheduling In Committee Health and Human Services Feb 19, 2026
SB1542 - Controlled substances; approval; use; research Arizona Psilocybin Clinical Research Passed Committee Kevin Payne Feb 18, 2026
HB5588 - Establish a regulated framework for the medical use of psilocybin to treat post-traumatic stress disorder (PTSD) West Virginia Psilocybin Therapeutic Access Died Rick Hillenbrand Feb 16, 2026
HB1477 - Public Health - Ibogaine Clinical Research Grant Program - Establishment (Veterans Mental Health Innovations Act) Maryland Ibogaine Clinical Research Introduced Darrell Odom Feb 13, 2026
HB4293 - Controlled dangerous substances; Veterans Mental Health Innovation Act; authorizing certain scientific research and clinical trials related to ibogaine; requiring registration; providing certain immunities; effective date. Oklahoma Ibogaine Clinical Research In Committee Daniel Pae Feb 10, 2026
SB527 - Public Health - Ibogaine Clinical Research Grant Program - Establishment (Veterans Mental Health Innovations Act) Maryland Ibogaine Clinical Research Introduced Kevin Harris Feb 9, 2026
SF2151 - A bill for an act removing psilocybin and psilocyn from the list of substances classified as schedule I controlled substances under Iowa's uniform controlled substances Act. Iowa Psilocybin Scheduling In Committee Doug Campbell Feb 5, 2026
HB336 - Use Of Fda-approved Psilocybin New Mexico Psilocybin Scheduling Died Dayan Hochman-Vigil Feb 4, 2026
SB5921 - Concerning psilocybin. Washington Psilocybin Therapeutic Access In Committee Jesse Salomon Feb 4, 2026
SB2561 - Ibogaine; authorize MSDH to select a consortium to conduct a drug development clinical trial to secure FDA's approval of. Mississippi Ibogaine Clinical Research Failed Josh Harkins Feb 3, 2026
H0859 - An act relating to psychedelic therapy and clinical drug development trials Vermont Psilocybin Therapeutic Access In Committee Brian Cina Feb 3, 2026
HB1796 - Allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions. New Hampshire Psilocybin Therapeutic Access Died Michael Moffett Feb 3, 2026
SB2562 - Mississippi Veterans PTSD Ibogaine Research Pilot Program; create. Mississippi Ibogaine Scheduling Failed Jeff Tate Feb 3, 2026
SB751 - Veterans and Former First Responders Research Pilot Program. California Psilocybin Clinical Research Failed Josh Becker Feb 2, 2026
HB7091 - Expanding Veterans’ Access to Emerging Treatments Act Federal Psilocybin Clinical Research In Committee Jack Bergman Feb 2, 2026
HB4640 - Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration West Virginia Psilocybin Scheduling Died Evan Worrell Feb 2, 2026
S1113 - Relative to removing criminal penalties for limited psilocybin possession Massachusetts Psilocybin Therapeutic Access In Committee Cindy Friedman Jan 29, 2026
H2532 - Relative to therapeutic psilocybin treatment centers Massachusetts Psilocybin Clinical Research In Committee Lindsay Sabadosa Jan 28, 2026
H2506 - Decriminalizing psilocybin as a treatment for PTSD and certain other conditions Massachusetts Psilocybin Therapeutic Access In Committee Steven Owens Jan 28, 2026
HF2085 - A bill for an act relating to the production and administration of psilocybin and providing penalties. Iowa Psilocybin Therapeutic Access In Committee John Wills Jan 26, 2026
SB1149 - Further providing for authority to control. Pennsylvania Psilocybin Therapeutic Access In Committee Tracy Pennycuick Jan 23, 2026
HB4721 - Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration West Virginia Psilocybin Scheduling Died Rick Hillenbrand Jan 22, 2026
A09583 - Establishes a research grant program to fund clinical trials of ibogaine for the treatment of veterans for post-traumatic stress disorder; creates a fund to provide monies for the research grant program. New York Ibogaine Clinical Research In Committee Robert Smullen Jan 21, 2026
H0497 - Amends existing law to revise provisions regarding controlled substances. Idaho Psilocybin Therapeutic Access In Committee Health and Welfare Committee Jan 20, 2026
S2283 - Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million. New Jersey Psilocybin Clinical Research Signed into Law Nicholas Scutari Jan 20, 2026
S3148 - "Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness. New Jersey Psilocybin Therapeutic Access Failed Nicholas Scutari Jan 13, 2026
A1526 - Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million. New Jersey Psilocybin Clinical Research Failed Clinton Calabrese Jan 13, 2026
A3852 - Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million. New Jersey Psilocybin Clinical Research Died Clinton Calabrese Jan 12, 2026
HB1433 - Concerning access to psychedelic substances. Washington Psilocybin Therapeutic Access In Committee Nicole Macri Jan 12, 2026
SB5201 - Concerning access to psychedelic substances. Washington Psilocybin Therapeutic Access In Committee Jesse Salomon Jan 12, 2026
SB5204 - Concerning ibogaine-assisted therapy. Washington Ibogaine Therapeutic Access In Committee Jesse Salomon Jan 12, 2026
S01801 - Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to veterans and first responders from New York state; establishes a psilocybin assisted therapy pilot program fund. New York Psilocybin Clinical Research In Committee Nathalia Fernandez Jan 9, 2026
A03845 - Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to veterans and first responders from New York state; establishes a psilocybin assisted therapy pilot program fund. New York Psilocybin Clinical Research In Committee Patrick Burke Jan 8, 2026
S00495 - Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor. New York Psilocybin Therapeutic Access In Committee Nathalia Fernandez Jan 7, 2026
A00628 - Legalizes adult possession and use of certain natural plant or fungus-based hallucinogens; grants certain protections for individuals lawfully using such hallucinogens; removes such hallucinogens from the list of schedule I controlled substances; makes related provisions. New York Psilocybin Scheduling In Committee Linda Rosenthal Jan 7, 2026
A03775 - Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor. New York Psilocybin Therapeutic Access In Committee Patrick Burke Jan 7, 2026
S04664 - Directs the commissioner of health, in conjunction with the commissioners of mental health and veterans' services, to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder, and the increasing rate of PTSD diagnoses in veterans and first responders. New York Ibogaine Therapeutic Access In Committee Jacob Ashby Jan 7, 2026
A01522 - Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction. New York Ibogaine Clinical Research In Committee David Weprin Jan 7, 2026
AB1103 - Controlled substances: research. California Psilocybin Clinical Research Signed into Law Chris Ward Oct 10, 2025
S1400 - Authorizing a pilot for the use of psychedelics in licensed treatment facilities Massachusetts Psilocybin Therapeutic Access In Committee Cindy Friedman Oct 2, 2025
HB3817 - Relating to ibogaine. Oregon Ibogaine Therapeutic Access Failed Alek Skarlatos Jun 27, 2025
HB4686 - Crimes: controlled substances; creating, manufacturing, possessing, or using psilocybin or psilocin; allow under certain circumstances. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 7404a. Michigan Psilocybin Therapeutic Access In Committee Mike McFall Jun 25, 2025
SF659 - A bill for an act relating to state government and finances, including by making, modifying, limiting, or reducing appropriations, distributions, or transfers; authorizing expenditure of unappropriated moneys in special funds; providing for properly related matters including crystalline polymorph psilocybin, medical residency and fellowship positions, state membership in the Iowa individual health benefit reinsurance association, student abuse by school employees, modified supplemental amounts for school budgets, wagering taxes, a state fire marshal study, certain legislative interim studies, and 911 emergency communications services; making corrections; and including effective date, applicability, and retroactive applicability provisions. (Formerly SSB 1241.) Effective date: 06/11/2025, 07/01/2025. Applicability date: 01/01/2020, 04/30/2025, 07/01/2025. Iowa Psilocybin Scheduling Signed into Law Appropriations Jun 11, 2025
HB2387 - Relating to psilocybin; and declaring an emergency. Oregon Psilocybin Therapeutic Access Signed into Law Dacia Grayber Jun 11, 2025
HF383 - A bill for an act relating to the controlled substance crystalline polymorph psilocybin. (Formerly HF 14.) Vetoed 6-11-25. Iowa Psilocybin Scheduling Vetoed Health And Human Services Jun 11, 2025
SB2308 - Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment. Texas Ibogaine Clinical Research Signed into Law Tan Parker Jun 11, 2025
LD1034 - An Act to Decriminalize Personal Possession of Therapeutic Amounts of Psilocybin for Adults Maine Psilocybin Therapeutic Access Failed Grayson Lookner Jun 10, 2025
HB528 - Amending the penalties for the possession and use of psilocybin for persons 18 years of age or older. New Hampshire Psilocybin Therapeutic Access Died Kevin Verville Jun 5, 2025
AB378 - Creates the Alternative Therapy Pilot Program. (BDR 40-820) Nevada Psilocybin Clinical Research Failed Max Carter Jun 3, 2025
SJR10 - Urges Congress to take certain actions relating to the therapeutic use of certain psychedelic compounds. (BDR R-801) Nevada Psilocybin Therapeutic Access Signed into Law Rochelle Nguyen Jun 1, 2025
HB07065 - An Act Concerning The Decriminalization Of Possession Of Small Amounts Of Psilocybin. Connecticut Psilocybin Decriminalization Tabled Judiciary Committee May 20, 2025
HB4014 - Relating to a study on the use of psychedelic therapies in the treatment of certain conditions. Texas Psilocybin Therapeutic Access Died John Bucy May 19, 2025
HB951 - Modifies provisions relating to alternative therapies and treatments, including psilocybin Missouri Psilocybin Therapeutic Access Died Matthew Overcast May 15, 2025
SSB1241 - A bill for an act relating to state government and finances, including by making, modifying, limiting, or reducing appropriations, distributions, or transfers, authorizing expenditure of unappropriated moneys in special funds, providing for properly related matters including crystalline polymorph psilocybin and medical residency and fellowship positions, making corrections, and including effective date and retroactive applicability provisions.(See SF 659.) Iowa Psilocybin Scheduling Died Appropriations May 14, 2025
HB4813 - Relating to the scheduling of certain controlled substances in response to certain actions by the United States Food and Drug Administration with respect to those substances. Texas Psilocybin Scheduling Died Tom Oliverson May 13, 2025
HB1439 - Further providing for authority to control. Pennsylvania Psilocybin Therapeutic Access In Committee Jennifer O'Mara May 12, 2025
HB3717 - Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy. Texas Ibogaine Therapeutic Access Died Cody Harris May 12, 2025
HB2623 - Innovative Therapies Centers of Excellence Act of 2025 Federal Psilocybin Therapeutic Access In Committee Luis Correa May 8, 2025
HB829 - Modifies provisions relating to alternative therapies and treatments, including psilocybin Missouri Psilocybin Therapeutic Access Died Richard West May 6, 2025
SB3005 - Relating to a study on the use of psychedelic therapies in the treatment of certain conditions. Texas Psilocybin Therapeutic Access Died Cesar Blanco Apr 29, 2025
HF620 - A bill for an act relating to the production of psilocybin and the administration of psilocybin to persons with post-traumatic stress disorder, and providing penalties.(See HF 978.) Iowa Psilocybin Therapeutic Access Died John Wills Apr 28, 2025
HB3344 - Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine West Virginia Ibogaine Therapeutic Access Died Evan Worrell Apr 11, 2025
SB219 - Medical Psilocybin Act New Mexico Psilocybin Therapeutic Access Signed into Law Craig Brandt Apr 7, 2025
SB1135 - Crystalline polymorph psilocybin; regulations for prescribing, etc. Virginia Psilocybin Scheduling Vetoed Jennifer Boysko Apr 2, 2025
HB1063 - FDA-Approved Crystalline Polymorph Psilocybin Use Colorado Psilocybin Scheduling Signed into Law Kyle Brown Mar 31, 2025
SB2064 - The scheduling of controlled substances; and to declare an emergency. North Dakota Psilocybin Scheduling Signed into Law Judiciary Mar 27, 2025
HB3343 - Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration West Virginia Psilocybin Scheduling Died Evan Worrell Mar 27, 2025
S568 - Innovative Treatments for Mental Health Act North Carolina Psilocybin Therapeutic Access Died Sophia Chitlik Mar 26, 2025
S568 - Innovative Treatments for Mental Health Act North Carolina Psilocybin Therapeutic Access Died Sophia Chitlik Mar 26, 2025
HF2699 - Psilocybin cultivation, possession, transportation, and personal use by individuals 21 years of age or older authorized; protections established; public education and harm reduction programs established; Psychedelic Medicine Board established; criminal penalties provided; rulemaking authorized; civil actions authorized; and money appropriated. Minnesota Psilocybin Decriminalization Died Andrew Smith Mar 24, 2025
HM58 - Study Psilocybin-based Medication Treatment New Mexico Psilocybin Therapeutic Access Died Dayan Hochman-Vigil Mar 14, 2025
SB90 - Modifies provisions relating to alternative therapies and treatments, including psilocybin Missouri Psilocybin Therapeutic Access Died Stephen Webber Mar 12, 2025
S0106 - An act relating to continuing the Psychedelic Therapy Advisory Working Group Vermont Psilocybin Therapeutic Access Died Martine Gulick Mar 11, 2025
H0452 - An act relating to decriminalization of psilocybin-containing mushrooms and the establishment of the Psilocybin Therapeutic Consultation Program Vermont Psilocybin Therapeutic Access Died Brian Cina Feb 28, 2025
LB72 - Change provisions relating to controlled substances schedules under the Uniform Controlled Substances Act Nebraska Psilocybin Therapeutic Access Signed into Law Robert Hallstrom Feb 26, 2025

Psychedelic legislation by state